Literature DB >> 26257212

t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia.

Candida Vitale1, Xinyan Lu2, Balkees Abderrahman1, Koichi Takahashi1, Farhad Ravandi1, Elias Jabbour1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26257212      PMCID: PMC4807602          DOI: 10.1002/ajh.24143

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  10 in total

1.  Simultaneous occurrence of bcr-abl and inv16 in a case of M1 acute myeloid leukemia.

Authors:  M Svaldi; A Lanthaler; R Venturi; P Coser; M Mitterer
Journal:  Leukemia       Date:  2001-04       Impact factor: 11.528

2.  Subclones with the t(9;22)/BCR-ABL1 rearrangement occur in AML and seem to cooperate with distinct genetic alterations.

Authors:  Ulrike Bacher; Torsten Haferlach; Tamara Alpermann; Melanie Zenger; Andreas Hochhaus; Dietrich W Beelen; Michael Uppenkamp; Mathias Rummel; Wolfgang Kern; Susanne Schnittger; Claudia Haferlach
Journal:  Br J Haematol       Date:  2011-01-31       Impact factor: 6.998

3.  p190(BCR-ABL) rearrangement as a secondary change in a case of acute myelo-monocytic leukemia with inv(16)(p13q22).

Authors:  Marie Cividin; Françoise Brizard; Nathalie Sorel; Marc Renaud; François Guilhot; André Brizard
Journal:  Leuk Res       Date:  2004-01       Impact factor: 3.156

4.  A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).

Authors:  M Kim; J Lim; Y Kim; K Han; C-S Kang; H-J Kim; W-S Min
Journal:  Leukemia       Date:  2006-04       Impact factor: 11.528

5.  Inversion of chromosome 16 with the Philadelphia chromosome in acute myelomonocytic leukemia with eosinophilia. Report of two cases.

Authors:  L M Secker-Walker; G J Morgan; T Min; G J Swansbury; J Craig; T Yamada; L Desalvo; J W Medina; V Chowdhury; R P Donahue
Journal:  Cancer Genet Cytogenet       Date:  1992-01

Review 6.  De novo acute myeloid leukemia with Philadelphia chromosome (BCR-ABL) and inversion 16 (CBFB-MYH11): report of two cases and review of the literature.

Authors:  Christine G Roth; Lydia Contis; Saurabh Gupta; Mounzer Agha; Eric Safyan
Journal:  Leuk Lymphoma       Date:  2011-02-01

7.  p210 BCR/ABL1 as a secondary change in a patient with acute myelomonocytic leukemia (M4Eo) with inv(16).

Authors:  Hai-ping Dai; Yong-quan Xue; Li-li Wu; Jin-lan Pan; Yan-lei Gong; Ya-fang Wu; Jun Zhang; De-pei Wu; Su-ning Chen
Journal:  Int J Hematol       Date:  2012-10-11       Impact factor: 2.490

8.  Standard Ph chromosome, t(9;22)(q34;q11), as an additional change in a patient with acute myelomonocytic leukemia (M4Eo) associated with inv(16)(p13q22)

Authors:  I Miura; H Takatsu; A Yamaguchi; K Hashimoto; T Nimura; T Nishinari; H Niitsu; A B Miura
Journal:  Am J Hematol       Date:  1994-01       Impact factor: 10.047

Review 9.  Acute myeloid leukemia with inv(16) with CBFB-MYH11, 3'CBFB deletion, variant t(9;22) with BCR-ABL1, and del(7)(q22q32) in a pediatric patient: case report and literature review.

Authors:  Carlos A Tirado; Federico Valdez; Laura Klesse; Nitin J Karandikar; Naseem Uddin; Arnaldo Arbini; Nicholas Fustino; Robert Collins; Sangeeta Patel; Ruth L Smart; Rolando Garcia; Jeff Doolittle; Weina Chen
Journal:  Cancer Genet Cytogenet       Date:  2010-07-01

10.  Characteristics of hematologic malignancies with coexisting t(9;22) and inv(16) chromosomal abnormalities.

Authors:  Eunhee Han; Hyeyoung Lee; Myungshin Kim; Yonggoo Kim; Kyungja Han; Sung-Eun Lee; Hee-Je Kim; Dong-Wook Kim
Journal:  Blood Res       Date:  2014-03-24
  10 in total
  2 in total

1.  BCR-ABL+ acute myeloid leukemia: are we always dealing with a high-risk disease?

Authors:  Nina Rosa Neuendorff; Philipp Hemmati; Renate Arnold; Jana Ihlow; Bernd Dörken; Carsten Müller-Tidow; Jörg Westermann
Journal:  Blood Adv       Date:  2018-06-26

Review 2.  NPM1 Mutated, BCR-ABL1 Positive Myeloid Neoplasms: Review of the Literature.

Authors:  Gianfranco Catalano; Pasquale Niscola; Cristina Banella; Daniela Diverio; Malgorzata Monika Trawinska; Stefano Fratoni; Rita Iazzoni; Paolo De Fabritiis; Elisabetta Abruzzese; Nelida Ines Noguera
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-11-01       Impact factor: 2.576

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.